FMP
LENSAR, Inc.
LNSR
NASDAQ
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
3.18 USD
-0.07 (-2.2%)
About
ceo
Mr. Nicholas T. Curtis
sector
Healthcare
industry
Medical - Devices
website
https://www.lensar.com
exchange
NASDAQ
Description
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
CIK
0001320350
ISIN
US52634L1089
CUSIP
52634L108
Address
2800 Discovery Drive
Phone
888 536 7271
Country
US
Employee
130
IPO Date
Oct 2, 2020
Key Executives
